Who owns ENTERO THERAPEUTICS INC?
- Ticker: GRDX
- CUSIP Number: 33749p507
Tip: Access positions for across all investors
Analyze quarterly positions in Entero Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Entero Therapeutics stock
Who bought or sold ENTERO THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Renaissance Technologies | 176k | $827k | -4% | Jun 2026 |
|
| Citadel Advisors | 85k | $400k | 100% | Jun 2026 |
|
| Federation des caisses Desjardins du Quebec | 76k | $358k | 60% | Jun 2026 |
|
| Vanguard Capital Management | 74k | $347k | 305% | Jun 2026 |
|
| Geode Capital Management | 60k | $281k | 80% | Jun 2026 |
|
| Jane Street | 49k | $231k | 289% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 34k | $159k | 107% | Jun 2026 |
|
| State Street Corporation | 23k | $47k | 0% | Mar 2026 |
|
| Hrt Financial | 21k | $98k | 100% | Jun 2026 |
|
| Independent Advisor Alliance | 15k | $70k | 100% | Jun 2026 |
|
| Northern Trust | 14k | $65k | 100% | Jun 2026 |
|
| Harbour Investments | 5.9k | $28k | -27% | Jun 2026 |
|
| Jones Financial Companies, L.L | 2.0k | $8.8k | 100% | Jun 2026 |
|
| Tower Research Capital | 1.4k | $6.8k | 15% | Jun 2026 |
|
| Barclays | 380.00 | $1.8k | 100% | Jun 2026 |
|
| SBI Securities | 31.00 | $144.999400 | -94% | Jun 2026 |
|
| Caitong International Asset Management | 21.00 | $98.000700 | 100% | Jun 2026 |
|
| Citigroup | 1.00 | $2.000000 | 100% | Mar 2026 |
|
| Danske Bank A/s | 1.00 | $5.000000 | 0% | Jun 2026 |
|
| Advisor Group Holdings | 1.00 | $4.000000 | 0% | Jun 2026 |
|
Who sold out of Entero Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| UBS Group | Mar 2026 | 3.2k | $6.4k |